ÂÜÀòÂÒÂ×

Natalie Yivgi-Ohana is a seasoned professional in the field of biochemistry and medical sciences, holding a Ph.D. from The Hebrew University of Jerusalem. Currently serving as a member at 8400 The Health Network since September 2019, Natalie also holds the positions of CEO and CTO at Minovia Therapeutics, a role maintained since December 2011. Prior experience includes a postdoctoral fellowship at the Weizmann Institute of Science from 2007 to 2010. Educational credentials further include a Master’s Degree in Human Reproduction from Bar-Ilan University and a B.Sc. in Medical Sciences from Ben-Gurion University of the Negev.